Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
People with hormone-sensitive or autoimmune conditions Some ingredients may influence hormone activity or immune function, which could worsen conditions like endometriosis, uterine fibroids, or certain cancers, as well as autoimmune disorders such as lupus or rheumatoid arthritis.33 People who are pregnant, breastfeeding, or trying to conceive People taking medications that affect serotonin levels People with unexplained or severe symptoms Hormone-related symptoms like fatigue, irregular periods, or mood changes can sometimes be linked to underlying medical conditions
Orforglipron, developed by Eli Lilly, is a next-generation oral non-peptide small molecule GLP-1 agonist that has completed Phase 3 trials and filed for FDA approval
Potential benefits being explored include improved blood sugar regulation, reduced inflammation, quieter food noise, and better energy
Cross-border access rules for U.S
If approved, your provider will send your prescription to a state-licensed compounding pharmacy
US$ 28.89
US$ 27.13
US$ 27.08
US$ 28.43
US$ 21.84
US$ 28.15
US$ 22.73
US$ 28.69
US$ 26.86
